Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021

The South Korea mass vaccination programme administered 3.8 million doses of COVID-19 vaccinations between 26 February and 30 April 2021. After 173 suspected anaphylaxis reports to the nationwide monitoring system for adverse events following immunisation, 44 anaphylaxis cases were confirmed using B...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Eunju, Lee, Yeon-kyeong, Kim, Tae Eun, Hwang, Insob, Jung, Yeon Haw, Lee, Hye Ryeon, Song, Jeongsuk, Park, Youngjoon, Cho, Enhi, Lee, Yeon-Kyeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2021
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380974/
https://www.ncbi.nlm.nih.gov/pubmed/34414880
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.33.2100694
_version_ 1783741276548497408
author Lee, Eunju
Lee, Yeon-kyeong
Kim, Tae Eun
Hwang, Insob
Jung, Yeon Haw
Lee, Hye Ryeon
Song, Jeongsuk
Park, Youngjoon
Cho, Enhi
Lee, Yeon-Kyeng
author_facet Lee, Eunju
Lee, Yeon-kyeong
Kim, Tae Eun
Hwang, Insob
Jung, Yeon Haw
Lee, Hye Ryeon
Song, Jeongsuk
Park, Youngjoon
Cho, Enhi
Lee, Yeon-Kyeng
author_sort Lee, Eunju
collection PubMed
description The South Korea mass vaccination programme administered 3.8 million doses of COVID-19 vaccinations between 26 February and 30 April 2021. After 173 suspected anaphylaxis reports to the nationwide monitoring system for adverse events following immunisation, 44 anaphylaxis cases were confirmed using Brighton Collaboration case definitions. The rates per million doses were 18.2 cases and 6.2 cases for Vaxzevria and Comirnaty, respectively. Median time of onset was 14 min after vaccination and most cases had recovered at the time of review.
format Online
Article
Text
id pubmed-8380974
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-83809742021-09-01 Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021 Lee, Eunju Lee, Yeon-kyeong Kim, Tae Eun Hwang, Insob Jung, Yeon Haw Lee, Hye Ryeon Song, Jeongsuk Park, Youngjoon Cho, Enhi Lee, Yeon-Kyeng Euro Surveill Rapid Communication The South Korea mass vaccination programme administered 3.8 million doses of COVID-19 vaccinations between 26 February and 30 April 2021. After 173 suspected anaphylaxis reports to the nationwide monitoring system for adverse events following immunisation, 44 anaphylaxis cases were confirmed using Brighton Collaboration case definitions. The rates per million doses were 18.2 cases and 6.2 cases for Vaxzevria and Comirnaty, respectively. Median time of onset was 14 min after vaccination and most cases had recovered at the time of review. European Centre for Disease Prevention and Control (ECDC) 2021-08-19 /pmc/articles/PMC8380974/ /pubmed/34414880 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.33.2100694 Text en This article is copyright of the authors or their affiliated institutions, 2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Rapid Communication
Lee, Eunju
Lee, Yeon-kyeong
Kim, Tae Eun
Hwang, Insob
Jung, Yeon Haw
Lee, Hye Ryeon
Song, Jeongsuk
Park, Youngjoon
Cho, Enhi
Lee, Yeon-Kyeng
Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021
title Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021
title_full Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021
title_fullStr Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021
title_full_unstemmed Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021
title_short Reports of anaphylaxis after coronavirus disease 2019 vaccination, South Korea, 26 February to 30 April 2021
title_sort reports of anaphylaxis after coronavirus disease 2019 vaccination, south korea, 26 february to 30 april 2021
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380974/
https://www.ncbi.nlm.nih.gov/pubmed/34414880
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.33.2100694
work_keys_str_mv AT leeeunju reportsofanaphylaxisaftercoronavirusdisease2019vaccinationsouthkorea26februaryto30april2021
AT leeyeonkyeong reportsofanaphylaxisaftercoronavirusdisease2019vaccinationsouthkorea26februaryto30april2021
AT kimtaeeun reportsofanaphylaxisaftercoronavirusdisease2019vaccinationsouthkorea26februaryto30april2021
AT hwanginsob reportsofanaphylaxisaftercoronavirusdisease2019vaccinationsouthkorea26februaryto30april2021
AT jungyeonhaw reportsofanaphylaxisaftercoronavirusdisease2019vaccinationsouthkorea26februaryto30april2021
AT leehyeryeon reportsofanaphylaxisaftercoronavirusdisease2019vaccinationsouthkorea26februaryto30april2021
AT songjeongsuk reportsofanaphylaxisaftercoronavirusdisease2019vaccinationsouthkorea26februaryto30april2021
AT parkyoungjoon reportsofanaphylaxisaftercoronavirusdisease2019vaccinationsouthkorea26februaryto30april2021
AT choenhi reportsofanaphylaxisaftercoronavirusdisease2019vaccinationsouthkorea26februaryto30april2021
AT leeyeonkyeng reportsofanaphylaxisaftercoronavirusdisease2019vaccinationsouthkorea26februaryto30april2021

Ejemplares similares